About Us
Our Story
Team
Careers
News
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Select specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Confirm Password
TAVR (Transcatheter Aortic Valve Replacement)
By
Tufts Medical Center
November 2, 2017
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
Boston Scientific
Cerebral Embolic Protection: Data and Limitations in the Current Era…
Fri, May 8, 2020
Faculty:
Carlos Sanchez
,
Boston Scientific
,
Amar Krishnaswamy
,
Kendra Grubb
Boston Scientific
Cerebral Embolic Protection and the Low Risk TAVR Patient
Mon, Nov 1, 2021
Faculty:
Suzanne Baron
,
James Harvey
,
Boston Scientific
Boston Scientific
Lifetime Management and Cerebral Embolic Protection in TAVR
Thu, Apr 14, 2022
Faculty:
Boston Scientific
,
Thomas Waggoner
,
Kendra Grubb
Boston Scientific
Practical Use of SENTINEL™ Cerebral Protection System & Insights fro…
Wed, Dec 14, 2022
Faculty:
Michael Rinaldi
,
Vinod Thourani
,
Boston Scientific
24:31
Vinod Thourani
How Do I Treat Low Gradient & Severe Aortic Stenosis?
62:13
Medtronic
Hot Topics, Hotter Questions
Feat.
A. Almanfi,
G. Fontana,
S. Baron
12:45
Miami Valves
Suprasternal Direct Aortic Approach TAVR Avoid Sternotomy and Thraco…
Feat.
A. Kiser
04:27
Medtronic
Valve Durability Meta-Analysis
Feat.
G. Attizzani
70:52
Medtronic
Post-TAVR Coronary Access: Hands-on with the Heartroid
Feat.
D. Talreja
11:45
Medtronic
SURTAVI Five-Year Results
Feat.
M. Reardon,
N. Van Mieghem
12:19
Medtronic
A Closer Look: 5-Year Data from CoreValve US Pivotal and SURTAVI Tri…
Feat.
M. Reardon
36:11
ARCH Advanced Revascularization Symposium
The UPSTREAM Management of Aortic Stenosis in the Future
Feat.
M. Leon
17:08
JenaValve
TVT 2021 - The Future Role of TAVR in Aortic Regurgitation Therapy: …
Feat.
T. Vahl,
O. Ben-Yehuda,
M. Mack
64:51
Getinge
SCAI Scientific Sessions 2022 - MCS Support: Practical Use of IABP -…
Feat.
A. Truesdell,
M. Ansari
09:48
American College of Cardiology
PARTNER 3 Trial: Should TAVR or SAVR Be Performed Among Low-risk Pat…
Feat.
D. Adams,
V. Fuster,
R. Mehran,
A. Lala-Trindade,
V. Reddy
07:23
Medtronic .
Drs. Michael Reardon and Kendra Grubb’s Interview on the SVD Data Pr…
Feat.
M. Reardon,
K. Grubb
13:53
JenaValve
TVT 2021 - Characterizing the Transcatheter Need for High-Risk Sever…
Feat.
T. Vahl,
V. Thourani,
M. Mack,
H. Treede
12:45
Scripps Health: 2019 Eighth Annual Structural Heart Intervention and Imaging
Cerebral Protection for TAVR: When and Why
Feat.
D. Rizik
56:22
JenaValve
Aortic Regurgitation Webinar: A Disease State Review, Current Treatm…
Feat.
V. Thourani,
J. McCabe,
M. Russo
53:21
Medtronic
St. Francis Hospital & Heart Center Bicuspid Case with Post-Case…
Feat.
G. Petrossian,
N. Robinson,
J. Popma,
W. Chung
01:51
JenaValve
ALIGN-AR Call to Action - Refer Severe, Symptomatic AR Patients with…
Feat.
V. Thourani
11:39
JenaValve
Aortic Regurgitation Webinar - The ALIGN-AR Trial: Novel TAVR Device…
Feat.
J. Mccabe
13:59
JenaValve
TVT 2021 - Case Presentation: High-Risk Severe AR Treated with a Jen…
Feat.
T. Vahl,
L. Ranard,
M. Mack
91:27
JenaValve
TVT 2021 – High-Risk Severe AR with TAVR
Feat.
M. Mack,
T. Vahl,
V. Thourani,
O. Ben-Yehuda,
D. Daniels,
L. Ranard,
N. Hamid,
T. Cahill,
H. Treede,
D. Kereiakes